Principles and basic concepts of molecular imaging

Pediatric Radiology

Volumn 41, Issue 2, 2011, Pages 144-160

  Grenier, Nicolas ^a   Brader, Peter ^b  

^a UMR 5287   (France)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Molecular imaging; Pediatrics; Receptor imaging; Reporter gene imaging

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

CLINICAL PRACTICE; CLINICAL RESEARCH; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; GENE THERAPY; HUMAN; IMAGING SYSTEM; MEDICAL TECHNOLOGY; MOLECULAR BIOLOGY; MOLECULAR IMAGING; MOLECULAR PROBE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHAGOCYTOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNAL NOISE RATIO; GENE TARGETING; IN VIVO STUDY;

EID: 79953820994     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-010-1835-z     Document Type: Review

References (85)

1. Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316-333 (Pubitemid 32336342)
2. Judenhofer MS, Wehrl HF, Newport DF et al (2008) Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 14:459-465 (Pubitemid 351499385)
3. Hu S, Wang LV (2010) Photoacoustic imaging and characterization of the microvasculature. J Biomed Opt 15:011101
4. Davis SC, Pogue BW, Springett R et al (2008) Magnetic resonance-coupled fluorescence tomography scanner for molecular imaging of tissue. Rev Sci Instrum 79:064302
5. Cao L, Breithaupt M, Peter J (2010) Geometrical co-calibration of a tomographic optical system with CT for intrinsically co-registered imaging. Phys Med Biol 55:1591-1606
6. Dobrucki LW, Sinusas AJ (2010) PET and SPECT in cardiovascular molecular imaging. Nat Rev Cardiol 7:38-47
7. Choy G, Choyke P, Libutti SK (2003) Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging 2:303-312
8. van de Ven S, Wiethoff A, Nielsen T et al (2010) A novel fluorescent imaging agent for diffuse optical tomography of the breast: first clinical experience in patients. Mol Imaging Biol 12:343-348
9. Dothager RS, Flentie K, Moss B et al (2009) Advances in bioluminescence imaging of live animal models. Curr Opin Biotechnol 20:45-53
10. Frangioni JV (2009) The problem is background, not signal. Mol Imaging 8:303-304
11. Gessner R, Dayton PA (2010) Advances in molecular imaging with ultrasound. Mol Imaging 9:117-127
12. Vande Velde G, Baekelandt V, Dresselaers T et al (2009) Magnetic resonance imaging and spectroscopy methods for molecular imaging. Q J Nucl Med Mol Imaging 53:565-585
13. Blasberg RG, Tjuvajev JG (2003) Molecular-genetic imaging: current and future perspectives. J Clin Invest 111:1620-1629 (Pubitemid 38057741)
14. Weissleder R, Ntziachristos V (2003) Shedding light onto live molecular targets. Nat Med 9:123-128 (Pubitemid 36098273)
15. Penuelas I, Mazzolini G, Boan JF et al (2005) Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology 128:1787-1795 (Pubitemid 40824689)
16. Canet-Soulas E, Letourneur D (2007) Biomarkers of atherosclerosis and the potential of MRI for the diagnosis of vulnerable plaque. Magma 20:129-142 (Pubitemid 47075076)
17. Woollard KJ, Geissmann F (2010) Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 7:77-86
18. Nahrendorf M, Sosnovik DE, French BA et al (2009) Multimodality cardiovascular molecular imaging, Part II. Circ Cardiovasc Imaging 2:56-70
19. Sinusas AJ, Bengel F, Nahrendorf M et al (2008) Multimodality cardiovascular molecular imaging, part I. Circ Cardiovasc Imaging 1:244-256
20. Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452:580-589 (Pubitemid 351483372)
21. Weissleder R (2006) Molecular imaging in cancer. Science 312:1168-1171
22. Corot C, Robert P, Idee JM et al (2006) Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 58:1471-1504 (Pubitemid 44820503)
23. McAteer MA, Akhtar AM, von Zur MC et al (2010) An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide. Atherosclerosis 209:18-27
24. Modo M, Hoehn M, Bulte JW (2005) Cellular MR imaging. Mol Imaging 4:143-164 (Pubitemid 43143788)
25. Hauger O, Delalande C, Deminiere C et al (2000) Nephrotoxic nephritis and obstructive nephropathy: evaluation with MR imaging enhanced with ultrasmall superparamagnetic iron oxide-preliminary findings in a rat model. Radiology 217:819-826
26. Hauger O, Grenier N, Deminere C et al (2007) USPIO-enhanced MR imaging of macrophage infiltration in native and transplanted kidneys: initial results in humans. Eur Radiol 17:2898-2907 (Pubitemid 47603986)
27. Dousset V, Brochet B, Deloire MS et al (2006) MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR 27:1000-1005 (Pubitemid 44897675)
28. Saleh A, Schroeter M, Ringelstein A et al (2007) Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke. Stroke 38:2733-2737 (Pubitemid 47494011)
29. Sigovan M, Boussel L, Sulaiman A et al (2009) Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. Radiology 252:401-409
30. Reiner CS, Lutz AM, Tschirch F et al (2009) USPIO-enhanced magnetic resonance imaging of the knee in asymptomatic volunteers. Eur Radiol 19:1715-1722
31. Bierry G, Jehl F, Boehm N et al (2008) Macrophage activity in infected areas of an experimental vertebral osteomyelitis model: USPIO-enhanced MR imaging-feasibility study. Radiology 248:114-123
32. Kraitchman DL, Bulte JW (2008) Imaging of stem cells using MRI. Basic Res Cardiol 103:105-113 (Pubitemid 351356753)
33. de Vries IJ, Lesterhuis WJ, Barentsz JO et al (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 23:1407-1413 (Pubitemid 41679393)
34. Bessaad A, Sigovan M, Alsaid H et al (2010) M1-activated macrophages migration, a marker of aortic atheroma progression: a preclinical MRI study in mice. Invest Radiol 45:262-269
35. Oude Engberink RD, van der Pol SM, Dopp EA et al (2007) Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology 243:467-474 (Pubitemid 46649703)
36. Tai JH, Foster P, Rosales A et al (2006) Imaging islets labeled with magnetic nanoparticles at 1.5 Tesla. Diabetes 55:2931-2938 (Pubitemid 44923630)
37. Liu ZY, Wang Y, Liang CH et al (2009) In vitro labeling of mesenchymal stem cells with superparamagnetic iron oxide by means of microbubble-enhanced US exposure: initial experience. Radiology 253:153-159
38. Bernsen MR, Moelker AD, Wielopolski PA et al (2010) Labelling of mammalian cells for visualisation by MRI. Eur Radiol 20:255-274
39. Alsaid H, De Souza G, Bourdillon MC et al (2009) Biomimetic MRI contrast agent for imaging of inflammation in atherosclerotic plaque of ApoE-/- mice: a pilot study. Invest Radiol 44:151-158
40. Chaubet F, Bertholon I, Serfaty JM et al (2007) A new macromolecular paramagnetic MR contrast agent binds to activated human platelets. Contrast Media Mol Imaging 2:178-188 (Pubitemid 47542594)
41. Nahrendorf M, Jaffer FA, Kelly KA et al (2006) Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114:1504-1511 (Pubitemid 44527006)
42. Choi KS, Kim SH, Cai QY et al (2007) Inflammation-specific T1 imaging using anti-intercellular adhesion molecule 1 antibody-conjugated gadolinium diethylenetriaminepentaacetic acid. Mol Imaging 6:75-84
43. Daldrup-Link HE, Meier R, Rudelius M et al (2005) In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol 15:4-13
44. Towner RA, Smith N, Doblas S et al (2008) In vivo detection of c-Met expression in a rat C6 glioma model. J Cell Mol Med 12:174-186
45. Pirollo KF, Dagata J, Wang P et al (2006) A tumor-targeted nanodelivery system to improve early MRI detection of cancer. Mol Imaging 5:41-52
46. Heroux J, Gharib AM, Danthi NS et al (2010) High-affinity alphavbeta3 integrin targeted optical probe as a new imaging biomarker for early atherosclerosis: initial studies in Watanabe rabbits. Mol Imaging Biol 12:2-8
47. Artemov D, Mori N, Okollie B et al (2003) MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 49:403-408 (Pubitemid 36262806)
48. Funovics MA, Kapeller B, Hoeller C et al (2004) MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents. Magn Reson Imaging 22:843-850 (Pubitemid 38962321)
49. Gee MS, Upadhyay R, Bergquist H et al (2008) Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy. Radiology 248:925-935
50. Wang X, DeFrances MC, Dai Y et al (2002) A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol Cell 9:411-421 (Pubitemid 34195565)
51. Towner RA, Smith N, Tesiram YA et al (2007) In vivo detection of c-MET expression in a rat hepatocarcinogenesis model using molecularly targeted magnetic resonance imaging. Mol Imaging 6:18-29
52. Weissleder R, Moore A, Mahmood U et al (2000) In vivo magnetic resonance imaging of transgene expression. Nat Med 6:351-355
53. Chang SS (2004) Overview of prostate-specific membrane antigen. Rev Urol 6(Suppl 10):S13-S18
54. Serda RE, Adolphi NL, Bisoffi M et al (2007) Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging. Mol Imaging 6:277-288 (Pubitemid 47509832)
55. Neubauer AM, Myerson J, Caruthers SD et al (2008) Gadolinium-modulated 19F signals from perfluorocarbon nano-particles as a new strategy for molecular imaging. Magn Reson Med 60:1066-1072
56. Schmieder AH, Winter PM, Caruthers SD et al (2005) Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles. Magn Reson Med 53:621-627 (Pubitemid 40332283)
57. Burtea C, Laurent S, Murariu O et al (2008) Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Cardiovasc Res 78:148-157 (Pubitemid 351430956)
58. Kaufmann BA, Sanders JM, Davis C et al (2007) Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 116:276-284 (Pubitemid 47196563)
59. Kang HW, Torres D, Wald L et al (2006) Targeted imaging of human endothelial-specific marker in a model of adoptive cell transfer. Lab Invest 86:599-609 (Pubitemid 43780441)
60. Boutry S, Laurent S, Elst LV et al (2006) Specific E-selectin targeting with a superparamagnetic MRI contrast agent. Contrast Media Mol Imaging 1:15-22
61. Radermacher KA, Beghein N, Boutry S et al (2009) In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy. Invest Radiol 44:398-404
62. Shaw SY (2009) Molecular imaging in cardiovascular disease: targets and opportunities. Nat Rev Cardiol 6:569-579
63. Amirbekian V, Lipinski MJ, Briley-Saebo KC et al (2007) Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci USA 104:961-966 (Pubitemid 46154719)
64. Hajra KM, Liu JR (2004) Apoptosome dysfunction in human cancer. Apoptosis 9:691-704 (Pubitemid 40941198)
65. Hersey P, Zhang XD (2003) Resistance of follicular lymphoma cells to chemotherapy is more than just BCL-2. Cancer Biol Ther 2:541-543
66. Rana A, Sathyanarayana P, Lieberthal W (2001) Role of apoptosis of renal tubular cells in acute renal failure: therapeutic implications. Apoptosis 6:83-102 (Pubitemid 32233957)
67. Hakumaki JM, Brindle KM (2003) Techniques: Visualizing apoptosis using nuclear magnetic resonance. Trends Pharmacol Sci 24:146-149 (Pubitemid 36293781)
68. Krishnan AS, Neves AA, de Backer MM et al (2008) Detection of cell death in tumors by using MR imaging and a gadolinium-based targeted contrast agent. Radiology 246:854-862
69. Sarda-Mantel L, Coutard M, Rouzet F et al (2006) 99mTc-annexin-V functional imaging of luminal thrombus activity in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 26:2153-2159 (Pubitemid 44253802)
70. Laufer EM, Winkens HM, Corsten MF et al (2009) PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5. Q J Nucl Med Mol Imaging 53:26-34
71. Zhao M, Beauregard DA, Loizou L et al (2001) Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 7:1241-1244 (Pubitemid 33063780)
72. Lancelot E, Amirbekian V, Brigger I et al (2008) Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler Thromb Vasc Biol 28:425-432
73. Lepage M, Dow WC, Melchior M et al (2007) Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch. Mol Imaging 6:393-403
74. Schellenberger E, Rudloff F, Warmuth C et al (2008) Protease-specific nanosensors for magnetic resonance imaging. Bioconjug Chem 19:2440-2445
75. Chen JW, Querol Sans M, Bogdanov A Jr et al (2006) Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology 240:473-481 (Pubitemid 44098644)
76. Nahrendorf M, Sosnovik D, Chen JW et al (2008) Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. Circulation 117:1153-1160 (Pubitemid 351552019)
77. [?twb=.27w]?〉Chen JW, Breckwoldt MO, Aikawa E et al (2008) Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis. Brain 131:1123-1133
78. Wu JC, Tseng JR, Gambhir SS (2004) Molecular imaging of cardiovascular gene products. J Nucl Cardiol 11:491-505 (Pubitemid 39107086)
79. Louie AY, Huber MM, Ahrens ET et al (2000) In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18:321-325
80. Edelstein ML, Abedi MR, Wixon J (2007) Gene therapy clinical trials worldwide to 2007 - an update. J Gene Med 9:833-842 (Pubitemid 47543250)
81. MacLaren DC, Gambhir SS, Satyamurthy N et al (1999) Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 6:785-791 (Pubitemid 29243651)
82. Rome C, Couillaud F, Moonen CT (2007) Gene expression and gene therapy imaging. Eur Radiol 17:305-319 (Pubitemid 46140303)
83. Grenier N, Hauger O, Eker O et al (2008) Molecular magnetic resonance imaging of the genitourinary tract: recent results and future directions. Magn Reson Imaging Clin N Am 16:627-641, viii
84. Quesson B, Vimeux F, Salomir R et al (2002) Automatic control of hyperthermic therapy based on real-time Fourier analysis of MR temperature maps. Magn Reson Med 47:1065-1072 (Pubitemid 34587397)
85. Eker O, Quesson B, Rome C et al (2010) Combination of cell delivery and thermo-inducible transcription for in vivo spatio-temporal control of gene expression: a feasibility study. Radiology In press